Press Releases

April 12, 2024 U.S. FDA Completes Inspection of Lupin’s Dabhasa Facility with No Observations

April 9, 2024 Lupin Launches First Generic Version of Oracea® (Doxycycline Capsules) in the United States

April 8, 2024 Lupin Receives Approval from U.S. FDA for Valbenazine Capsules

April 3, 2024 Lupin Appoints Dr. Ranjana Pathak as Chief Quality Officer

April 1, 2024 Lupin Receives Tentative Approval from U.S. FDA for Migalastat Capsules

March 28, 2024 Lupin Receives Approval from U.S. FDA for Eslicarbazepine Acetate Tablets

March 19, 2024 Lupin Receives Approval from U.S. FDA for Aripiprazole Tablets, USP

March 18, 2024 Lupin Appoints Christoph Funke as Chief Technical Operations Officer

March 15, 2024 Lupin Receives Approval from U.S. FDA for Doxycycline for Injection USP